|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 105.35 USD | -1.47% |
|
-2.61% | +56.54% |
| Market Cap | 11.96B 10.3B 9.66B 8.82B 16.61B 1,143B 16.67B 115B 44.72B 577B 44.89B 43.92B 1,913B | P/E 2026 * |
14.6x | P/E 2027 * | 11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 13.3B 11.46B 10.75B 9.81B 18.48B 1,271B 18.54B 127B 49.74B 642B 49.94B 48.85B 2,128B | EV / Sales 2026 * |
7.18x | EV / Sales 2027 * | 5.99x |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Halozyme Therapeutics, Inc.
| 1 day | -1.47% | ||
| 1 week | -2.61% | ||
| Current month | +27.64% | ||
| 1 month | +26.25% | ||
| 3 months | +54.52% | ||
| 6 months | +51.52% | ||
| Current year | +56.54% |
| 1 week | 104.7 |  | 109.66 |
| 1 month | 81.21 | | 109.66 |
| Current year | 61.32 | | 109.66 |
| 1 year | 61.22 | | 109.66 |
| 3 years | 32.83 | | 109.66 |
| 5 years | 29.85 | | 109.66 |
| 10 years | 8.18 | | 109.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 | Fiscal year | Chief Executive Officer | 60,000 | 0.0506% | ||
| 8/10/26 | Sell | Director | -1,626 | 0.0014% | ||
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -2.61% | +44.69% | +148.23% | 11.96B | |
| -0.80% | -2.75% | +78.28% | +36.19% | 366B | |
| +0.11% | +1.67% | +30.40% | -13.48% | 70.76B | |
| +1.74% | +3.38% | +4.70% | +1.10% | 8.72B | |
| 0.00% | +5.14% | -11.65% | +3.77% | 5B | |
| +2.66% | +3.16% | -26.37% | +23.81% | 4.59B | |
| -1.79% | -1.23% | -26.50% | +7.14% | 3.16B | |
| -1.04% | -4.62% | -3.61% | +39.76% | 2.54B | |
| -5.18% | -1.51% | -17.37% | -1.03% | 2.08B | |
| -4.61% | -5.81% | +245.95% | +1,169.21% | 1.71B | |
| Average | -1.04% | -0.24% | +31.85% | +141.47% | 47.65B | |
| Weighted average by Cap. | -0.63% | -1.85% | +66.08% | +34.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 1.6B 1.5B 1.37B 2.58B 177B 2.58B 17.77B 6.93B 89.43B 6.96B 6.81B 297B | 2.05B 1.77B 1.66B 1.51B 2.85B 196B 2.86B 19.66B 7.67B 98.94B 7.7B 7.53B 328B |
| Net income | 869M 749M 702M 641M 1.21B 83.03B 1.21B 8.33B 3.25B 41.91B 3.26B 3.19B 139B | 1.07B 920M 863M 788M 1.48B 102B 1.49B 10.24B 3.99B 51.52B 4.01B 3.92B 171B |
| Net Debt | 1.34B 1.16B 1.09B 991M 1.87B 128B 1.87B 12.88B 5.03B 64.84B 5.05B 4.94B 215B | 320M 275M 258M 236M 444M 30.54B 445M 3.06B 1.19B 15.41B 1.2B 1.17B 51.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$105.35 | -1.47% | 1,681,776 |
| 26-08-27 | US$106.92 | -0.13% | 1,364,730 |
| 26-08-26 | US$107.06 | -2.07% | 1,706,117 |
| 26-08-25 | US$109.32 | +0.63% | 1,598,158 |
| 26-08-24 | US$108.64 | +0.43% | 2,091,282 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
